Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 28, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	6.47	6.5	1.35	5.81	10.92	1.29
Short-Term Investments	0.07	0.06	0.13	0.35	0.83	0.02
Cash & Short-Term Investments	6.54	6.56	1.48	6.16	11.75	1.31
Cash Growth	36.51%	343.63%	-76.01%	-47.58%	794.97%	-2.69%
Accounts Receivable	0.17	0.08	0.02	0.12	0.02	0.23
Other Receivables	0.16	0.07	0.1	0.08	0.33	0.09
Receivables	0.33	0.15	0.13	0.2	0.34	0.31
Inventory	-	-	-	0.04	0.03	0.12
Prepaid Expenses	0.85	1.19	0.55	0.58	0.32	0.18
Total Current Assets	7.72	7.9	2.15	6.98	12.44	1.93
Property, Plant & Equipment	0.38	0.39	0.42	0.37	0.46	0.61
Other Intangible Assets	0.51	0.52	0.46	0.49	0.36	0.29
Other Long-Term Assets	0.06	0.06	0.05	-	-	-
Total Assets	8.68	8.87	3.08	7.83	13.27	2.83
Accounts Payable	1.28	0.38	0.23	0.12	0.06	0.05
Accrued Expenses	0.51	0.69	0.01	0.03	0.05	0.1
Short-Term Debt	-	-	-	-	0.01	-
Current Portion of Leases	0.03	0.03	0.03	0.04	0.04	0.04
Current Income Taxes Payable	-	-	-	-	0	0
Current Unearned Revenue	-	0	-	-	-	0.04
Total Current Liabilities	1.82	1.1	0.27	0.19	0.15	0.23
Long-Term Debt	-	-	-	-	-	0.03
Long-Term Leases	0.09	0.11	0.14	0.01	0.05	0.09
Total Liabilities	1.92	1.21	0.4	0.2	0.2	0.35
Common Stock	0.02	0.02	0.01	0.01	0.01	0
Additional Paid-In Capital	64.22	59.6	48.8	47.04	45.09	30.32
Retained Earnings	-56.98	-51.56	-45.76	-39.1	-31.83	-27.8
Comprehensive Income & Other	-0.12	-0.02	-	-	-	-
Total Common Equity	7.14	8.04	3.04	7.95	13.27	2.53
Minority Interest	-0.38	-0.38	-0.36	-0.32	-0.2	-0.04
Shareholders' Equity	6.76	7.66	2.68	7.63	13.06	2.48
Total Liabilities & Equity	8.68	8.87	3.08	7.83	13.27	2.83
Total Debt	0.12	0.14	0.16	0.05	0.1	0.16
Net Cash (Debt)	6.42	6.42	1.31	6.11	11.65	1.16
Net Cash Growth	38.22%	388.54%	-78.50%	-47.57%	907.32%	-14.26%
Net Cash Per Share	0.40	0.52	0.20	1.04	2.65	0.42
Filing Date Shares Outstanding	17.56	17.45	10.28	5.95	5.73	3
Total Common Shares Outstanding	17.56	15.81	8.09	5.95	5.73	3
Working Capital	5.9	6.8	1.88	6.78	12.29	1.7
Book Value Per Share	0.41	0.51	0.38	1.34	2.32	0.84
Tangible Book Value	6.64	7.52	2.58	7.46	12.9	2.23
Tangible Book Value Per Share	0.38	0.48	0.32	1.25	2.25	0.74
Machinery	0.54	0.51	0.47	0.44	0.39	0.39
Leasehold Improvements	0.26	0.26	0.26	0.26	0.26	0.26

Updated Jan 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q